Evidence map›Paper›PMID 33409961›Full record

Observational studyJournal of cardiovascular translational research2021

Angiographic Scoring System for Predicting Successful Percutaneous Coronary Intervention of In-Stent Chronic Total Occlusion.

Minglian Gong, Hongyu Peng, Zheng Wu, Wenzheng Li, Yun Lv, Yuan Lv, Ze Zheng, Tao An, Jing Zhang, Mingrui Lv and 4 more

Abstract readMulticenter StudyObservational StudyValidation Study
PubMed Publisher
In one paragraph

Observational study in Journal of cardiovascular translational research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Minglian GongDepartment of Cardiology, Dalian The Fifth People's Hospital, No. 890 Huanghe Road, Shahekou District, Dalian, 116021, Liaoning, China.
Hongyu PengDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung, and Blood Vessel Diseases, No. 2 Chaoyang Road, Chaoyang District, Beijing, 100029, China.
Zheng WuDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung, and Blood Vessel Diseases, No. 2 Chaoyang Road, Chaoyang District, Beijing, 100029, China.
Wenzheng LiDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung, and Blood Vessel Diseases, No. 2 Chaoyang Road, Chaoyang District, Beijing, 100029, China.
Yun LvDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung, and Blood Vessel Diseases, No. 2 Chaoyang Road, Chaoyang District, Beijing, 100029, China.
Yuan LvDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung, and Blood Vessel Diseases, No. 2 Chaoyang Road, Chaoyang District, Beijing, 100029, China.
Ze ZhengDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung, and Blood Vessel Diseases, No. 2 Chaoyang Road, Chaoyang District, Beijing, 100029, China.
Tao AnDepartment of Cardiology, Fuwai Hospital, Chinese Academy of Medical Science, Peking Union Medical College, National Center for Cardiovascular Disease, No.167 Beilishi Road, Xicheng District, Beijing, 100037, China.
Jing ZhangDepartment of Cardiology, Dalian The Fifth People's Hospital, No. 890 Huanghe Road, Shahekou District, Dalian, 116021, Liaoning, China.
Mingrui LvDepartment of Cardiology, Dalian The Fifth People's Hospital, No. 890 Huanghe Road, Shahekou District, Dalian, 116021, Liaoning, China.
Xin LiDepartment of Cardiology, Dalian The Fifth People's Hospital, No. 890 Huanghe Road, Shahekou District, Dalian, 116021, Liaoning, China.
Hangyu GongDepartment of Cardiology, Dalian The Sixth People's Hospital, No.269 Luganghuibo Road, Ganjingzi District, Dalian, 116033, Liaoning, China.
Yi MaoDepartment of Cardiology, Fuwai Hospital, Chinese Academy of Medical Science, Peking Union Medical College, National Center for Cardiovascular Disease, No.167 Beilishi Road, Xicheng District, Beijing, 100037, China. 13693305832@139.com.
Jinghua LiuDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung, and Blood Vessel Diseases, No. 2 Chaoyang Road, Chaoyang District, Beijing, 100029, China. liujinghua@vip.sina.com.
Beijing Anzhen Hospital · CNCapital Medical University · CNThe Third People's Hospital of Dalian City · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNSeventh People's Hospital of Dalian · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this study was to develop a scoring model to predict the technical success of recanalizing via antegrade approach in-stent chronic total occlusion (IS-CTO) by percutaneous coronary intervention (PCI). We retrospectively collected data from 474 patients who underwent an uneasy IS-CTO PCI via antegrade approach from January 2015 to December 2018, consecutively. We selected clinical and angiographic factors and utilized a derivation and validation cohort (4:1 sampling ratio) analysis. Factors with strong correlations with technical failure, according to multivariable analysis, were assigned 1 point, and a scoring system with a 4-point maximum was established. The model was then validated with a validation cohort. The overall procedural success rate was 77.4%. On multivariable analysis, the factors that correlated with technical failure were proximal bending (beta coefficient [β] = 2.142), tortuosity (β = 2.622), stent under expansion (β = 3.052), and poor distal landing zone (β = 2.004). The IS-CTO score demonstrated good calibration and excellent predicting capacity in the derivation (receiver-operator characteristic [ROC] area = 0.973 and Hosmer-Lemeshow chi-squared = 5.252; p = 0.072) and validation (ROC area = 0.976 and Hosmer-Lemeshow chi-squared = 0.916; p = 0.632) cohorts. In the validation subset, the IS-CTO score demonstrated superior performance to the Japanese chronic total occlusion score (J-CTO) and PROGRESS CTO scores for predicting technical success (area under the a curve [AUC] 0.976 vs. 0.642 vs. 0.579, respectively; difference in AUC between the IS-CTO score and J-CTO score = 0.334, p < 0.01; difference in AUC between the IS-CTO score and PROGRESS score = 0.397, p < 0.01). Our results suggest that the IS-CTO score system is a helpful tool to predict the technical success of IS-CTO PCI via antegrade approach in china. Graphical Abstract.

Indexed as

Coronary AngiographyDecision Support TechniquesStentsAgedBeijingChronic DiseaseCoronary Artery DiseaseCoronary OcclusionFemaleHumansMaleMiddle AgedPercutaneous Coronary InterventionPredictive Value of TestsReproducibility of ResultsRetreatmentIn-stent chronic total occlusionPercutaneous coronary interventionPredicting factorScoring system

Identifiers

PMID33409961
OpenAlexW3119251869

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.